CASE 30 ST. BENEDICT’S TEACHING HOSPITAL Merger Analysis. ***EXCEL SHEET***

profilejwilly18
Case30StBenedictsTeachingHospital-Student-6thedition.xlsx

Model

CASE 30 ST. BENEDICT'S TEACHING HOSPITAL: Merger Analysis 12/1/17
Copyright 2018 Foundation of the American College of Healthcare Executives. Not for sale.
Model without Questions, Student Version
This case consists of a valuation analysis on a 400-bed acute care hospital. The model uses both
discounted cash flow (DCF) and market multiple methodologies for the valuation. The DCF method
focuses on cash flows to equityholders. The INPUT DATA section of the model contains key
assumptions needed to generate the pro forma (forecasted) cash flow statements. In addition,
historical data used in the forecasting process is contained in its own section.
The model consists of a complete base case analysis--no changes need to be made to the existing
MODEL-GENERATED DATA section. However, values in the INPUT DATA section of the student
spreadsheet have been replaced by zeros. Students must select appropriate input values and enter
them into the cells with values colored red. After this is done, any error cells will be corrected and
the base case solution will appear. The KEY OUTPUT section includes the most important output
from the MODEL-GENERATED DATA section.
INPUT DATA: KEY OUTPUT:
(millions of $) (millions of $)
Cash flow data: Pro forma (forecasted) net cash flows:
Growth in revenues (2018-2022): 2018 $100.236
Inpatient 0% 2019 $100.236
Outpatient 0% 2020 $100.236
Nonoperating 0% 2021 $100.236
Patient services exp as a 2022 ERROR:#DIV/0!
% of net patient rev 0%
Percent of net CF 2018 EBITDA $100.236
retained for growth 0% Average 5-yr EBITDA ERROR:#DIV/0!
Annual inputs:
*Interest on **Interest on ***Cost Saving Acquisition value:
Year Current Debt Required Loans at Acquirer
2018 $0.000 $0.000 $0.000 DCF method ERROR:#DIV/0!
2019 $0.000 $0.000 $0.000 Market multiple method:
2020 $0.000 $0.000 $0.000 Applied to 2014 EBITDA $0.000
2021 $0.000 $0.000 $0.000 Applied to avg EBITDA ERROR:#DIV/0!
2022 $0.000 $0.000 $0.000 Applied to discharges $0.000
Long-term (2019 and beyond) *Interest on Lafayette General's current debt.
constant growth rate 0%
**Interest on any borrowings required to expand
Market data: the asset base or to fund the acquisition.
Discount rate (cost of equity) 0%
EBITDA multiple 0 ***Cost savings at St. Benedict's due to any
Market value to discharges ratio $0 synergistic benefits that will accrue at
the acquirer as opposed to at the target.
Operating data:
Expected number of discharges 0
HISTORICAL DATA:
Lafayette General Hospital
Historical Income Statements:
(Millions of Dollars)
2013 2014 2015 2016 2017
Inpatient revenue $42.472 $46.014 $53.410 $58.650 $59.513
Outpatient revenue 28.314 30.676 35.606 39.100 39.675
Net patient service revenue $70.786 $76.690 $89.016 $97.750 $99.188
Nonoperating revenue 1.922 1.515 1.367 1.725 1.048
Total revenues $72.708 $78.205 $90.383 $99.475 $100.236
Patient services expenses $60.245 $73.858 $81.525 $90.645 $89.505
Interest expense 3.045 3.147 3.093 3.002 2.980
Depreciation 3.466 3.689 4.395 4.258 6.031
Total expenses $66.756 $80.694 $89.013 $97.905 $98.516
Net income $5.952 ($2.489) $1.370 $1.570 $1.720
MODEL-GENERATED DATA:
Lafayette General Hospital
Pro Forma (Forecasted) Cash Flow Statements:
(Millions of Dollars)
2018 2019 2020 2021 2022
Inpatient revenue $59.513 $59.513 $59.513 $59.513 $59.513
Outpatient revenue 39.675 39.675 39.675 39.675 39.675
Net patient service revenue $99.188 $99.188 $99.188 $99.188 $99.188
Nonoperating revenue 1.048 1.048 1.048 1.048 1.048
Total revenues $100.236 $100.236 $100.236 $100.236 $100.236
Patient services expenses $0.00 $0.00 $0.00 $0.00 $0.00
Interest expense 0.000 0.000 0.000 0.000 0.000
Total expenses $0.000 $0.000 $0.000 $0.000 $0.000
Net operating cash flow $100.236 $100.236 $100.236 $100.236 $100.236
Cost savings at teaching (other) hospital 0.000 0.000 0.000 0.000 0.000
Growth retentions 0.000 0.000 0.000 0.000 0.000
Terminal value ERROR:#DIV/0!
Net cash flow to equityholders $100.236 $100.236 $100.236 $100.236 ERROR:#DIV/0!
EBITDA $100.236 $100.236 $100.236 $100.236 ERROR:#DIV/0!
Average 5-year EBITDA ERROR:#DIV/0!
Valuation Results:
(Millions of Dollars)
Value according to DCF method ERROR:#DIV/0!
Value according to market multiple method:
Applied to 2014 EBITDA $0.000
Applied to average 2014-2018 EBITDA ERROR:#DIV/0!
Applied to number of discharges $0.000
Sensitivity of DCF Value to Terminal Growth Rate and Discount Rate Estimates:
Discount Rate
ERROR:#DIV/0! 12% 13% 14% 15% 16% 17% 18%
1% $883.559 $810.454 $748.580 $695.531 $649.541 $609.289 $573.762
TV 2% $941.470 $857.027 $786.624 $727.020 $675.903 $631.577 $592.770
Growth 3% $1,012.249 $912.915 $831.584 $763.757 $706.320 $657.049 $614.312
Rate 4% $1,100.724 $981.223 $885.536 $807.174 $741.807 $686.440 $638.931
5% $1,214.477 $1,066.607 $951.478 $859.274 $783.746 $720.729 $667.338
6% $1,366.148 $1,176.386 $1,033.906 $922.952 $834.073 $761.252 $700.479
7% $1,578.488 $1,322.759 $1,139.884 $1,002.550 $895.583 $809.880 $739.647
END